CUSIP: 002120103
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,525,532
-
Share change
-
+203,141
-
Total reported value
-
$61,338,000
-
Price per share
-
$3.50
-
Number of holders
-
39
-
Value change
-
+$205,314
-
Number of buys
-
14
-
Number of sells
-
16
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2018
-
Previous quarter:
Q3 2017
Recent filing periods for CUSIP 002120103:
Institutional Holders of ATYR PHARMA INC - COM (LIFE) as of Q4 2017
As of 31 Dec 2017,
ATYR PHARMA INC - COM (LIFE) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,525,532 shares.
The largest 10 holders included
FMR LLC, EcoR1 Capital, LLC, Redmile Group, LLC, Polaris Venture Management Co. V, L.L.C., Viking Global Investors LP, Alyeska Investment Group, L.P., Artal Group S.A., Vanguard Group Inc, Rock Springs Capital Management LP, and BlackRock Inc..
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.